CanHFiciciogluMDPhD

Medical Genetics • Philadelphia, PA

Clinical Biochemical Genetics, Clinical Genetics

Professor of Pediatrics, Perelman School of Medicine

Join to view full profile

Dr. Ficicioglu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ficicioglu's full profile

Already have an account?

Office
3401 Civic Center Blvd
Childrens Hospital of Philadelphia Metabolism
Philadelphia, PA 19104
Phone+1 215-590-3376

Fax+1 215-590-4297

Education & Training

Westchester Medical CenterResidency, Pediatrics, 2001 - 2002
Montefiore Medical Center/Albert Einstein College of MedicineResidency, Pediatrics, 2000 - 2001
Brigham and Women's Hospital/Children's Hospital/Harvard Medical SchoolResidency, Internal Medicine/Pediatrics, 1998 - 1999
Istanbul University FomClass of 1985

Certifications & Licensure

NJ State Medical License 2016 - 2025
PA State Medical License 2002 - 2024
NC State Medical License 2022 - 2022
NY State Medical License 2002 - 2004
American Board of Medical Genetics and Genomics Clinical Biochemical Genetics
American Board of Pediatrics Pediatrics

Clinical Trials

Fluorodeoxyglucose Positron Emission Tomography (FDG PET) Findings in Patients With Phenylketonuria Before and After KUVAN Therapy Start of enrollment: 2010 Mar 01
Completed
Not Applicable
Mucopolysaccharidosis (MPS) I, II, and VI Screening in a High-Risk Population With Previous Surgical Repair or Presence of Inguinal and/or Umbilical Hernia in Combination With Pediatric ENT Surgery (The HATT Project) Start of enrollment: 2014 May 21
Terminated
A Study of the Safety, Efficacy and Pharmacokinetics of Glycerol Phenylbutyrate in Pediatric Subjects Under 2 Years of Age With Urea Cycle Disorders Start of enrollment: 2014 Dec 31
Completed
Phase 4
Natural History Study of Infantile and Juvenile GM1 Gangliosidosis (GM1) Patients Start of enrollment: 2020 Jun 12
Recruiting
Early Access Program With Arimoclomol in US Patients With NPC
Available
Roles: Principal Investigator, Contact
A Study to Determine the Efficacy and Safety of Tividenofusp Alfa (DNL310) vs Idursulfase in Pediatric Participants With Neuronopathic (nMPS II) or Non-Neuronopathic Mucopolysaccharidosis Type II (nnMPS II) Start of enrollment: 2022 Jul 21
Recruiting
Phase 2, Phase 3
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Monitoring and integrated care coordination of patients with alpha-mannosidosis: A global Delphi consensus study.
Nathalie Guffon, Barbara K Burton, Can Ficicioglu, Martin Magner, Mercedes Gil-Campos
Molecular Genetics and Metabolism. 2024-08-01
2 citations
Efficacy and safety of sapropterin before and during pregnancy: Final analysis of the Kuvan® Adult Maternal Paediatric European Registry (KAMPER) maternal and Phenylke...
François Feillet, Can Ficicioglu, Florian B Lagler, Nicola Longo, Ania C Muntau
Journal of Inherited Metabolic Disease. 2024-07-01
3 citations
A multinational study of acute and long-term outcomes of Type 1 galactosemia patients who carry the S135L (c.404C > T) variant of GALT.
Quinton S Katler, Karolina M Stepien, Nathan Paull, Sneh Patel, Michael Adams
Journal of Inherited Metabolic Disease. 2022-11-01

Journal Articles

TANGO2: Expanding the Clinical Phenotype and Spectrum of Pathogenic Variants
Jennifer N Dines, Heather C Mefford, Barbara Burton, Joline Dalton, Alice Basinger, Peter Karachunski, Can Ficicioglu, Katherine L Helbig, Nature